As the smoke clears from the 2025 election cycle, the cannabis community finds itself in familiar territory: hopeful, cautious, and slightly paranoid. With President Trump back in office and a Republican-controlled Congress, the question isn’t just “Will weed be legalized?”—it’s “Will the feds leave us alone?”
The Federal Whiplash
Despite Trump’s occasional nods to state autonomy, recent moves by his administration suggest a more aggressive stance. The Department of Justice has quietly resumed prosecutions for simple possession on federal lands—even in states where cannabis is legal. That means lighting up in a national park or even carrying a joint near a federal courthouse could land you in hot water.
This rollback echoes the Jeff Sessions era, when federal enforcement loomed large despite booming state markets. The contradiction is glaring: Trump says he supports states’ rights, but his DOJ is flexing federal muscle in ways that undermine local laws. For businesses and consumers alike, this creates uncertainty—should dispensaries trust state licenses, or prepare for federal raids? Should patients risk traveling with medical cannabis across state lines, even if both states allow it?
Rescheduling ≠ Legalization
Adding to the confusion, Trump has expressed support for rescheduling cannabis—from Schedule I to Schedule III. While this would ease research restrictions and allow cannabis companies to deduct business expenses, it wouldn’t legalize recreational use or stop federal prosecutions. Rescheduling would help pharmaceutical companies and researchers, but it leaves everyday consumers in the same legal gray zone.
In short: rescheduling is a tax break, not a green light. It’s a step forward for science, but not for social justice. The thousands of people still facing cannabis-related charges would see little relief, and the broader legalization movement would remain stalled.
The Hemp Hypocrisy
Let’s not forget the November 2025 spending bill, which included a provision banning consumable hemp products with any detectable THC. This move guts the delta-8 and delta-10 market—industries that exploded after Trump’s 2018 Farm Bill legalized hemp. Small businesses that thrived on hemp-derived cannabinoids now face closures, lawsuits, and confusion. The irony is hard to miss: the same administration that once championed hemp as an agricultural win is now cutting off one of its most profitable branches.
For farmers, processors, and retailers, this is more than a policy shift—it’s a livelihood at risk. The hemp rollback highlights how quickly federal priorities can change, leaving entrepreneurs scrambling to adapt.
States Still Lead the Way
With federal policy in flux, states continue to blaze their own trail. Florida’s 2026 ballot initiative could legalize recreational cannabis, and other states are expanding access through legislative action. States like Minnesota, Colorado, and California are refining equity programs, addressing expungement, and building frameworks for sustainable cannabis economies. The real momentum is local, not federal.
This state-driven progress underscores a broader truth: cannabis reform in America has always been bottom-up. Federal policy lags behind, while voters and legislatures push forward. Even under a Trump administration, the states remain the laboratories of democracy—and cannabis is one of their most active experiments.
What’s Next?
For cannabis advocates, the path forward is clear:
- Push for federal non-interference in state markets
- Educate voters on the difference between rescheduling and legalization
- Support state-level initiatives that protect access and equity
- Demand consistency in hemp and cannabis policy to protect small businesses
Trump’s cannabis policy is a mixed bag—part libertarian, part authoritarian, and wholly unpredictable. But if history has taught us anything, it’s that the grassroots always grow through the cracks. The cannabis movement has survived decades of federal hostility, and it will continue to thrive as long as states and communities keep pushing forward.